Delivery Order SPE2DX22D0090-SPE2D826FAB9H
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $31,726.08 to AmerisourceBergen Drug Corp on November 1, 2025, with an ultimate completion date of November 3, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $369,718.44 to AmerisourceBergen Drug Corp on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $10,316.76 to AmerisourceBergen Drug Corp on September 1, 2025, with completion targeted for September 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $116,799.91 to AmerisourceBergen Drug Corp on October 18, 2025, with an ultimate completion date of October 20, 2025. This firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The company, headquartered in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,250.47 to AmerisourceBergen Drug Corp on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The vendor, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,790.80 to AmerisourceBergen Drug Corp on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $649,655.50 to AmerisourceBergen Drug Corp on November 5, 2025, with an ultimate completion date of November 6, 2025. This firm fixed-price delivery order, issued under a non-set-aside competitive award, draws from AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. The contract is...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $17,056.07 to AmerisourceBergen Drug Corp on August 25, 2025, with completion expected by August 26, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,125.06 to AmerisourceBergen Drug Corp on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was made on a non-set-aside, competitively...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $14,257.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, with completion expected by October 21, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order is to be performed at AmerisourceBergen's corporate...
- SPE2DX22D0090Indefinite Delivery Contract
- SPE2DX22D0090-SPE2D826FAB9HDelivery Order
The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,363.11 to AmerisourceBergen Drug Corp on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price delivery order is a non-set-aside award issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a prime pharmaceutical distributor and healthcare solutions provider specializing in federal medical procurement for military and veteran healthcare systems. As a child order under the broader IDC vehicle, this delivery order represents one of numerous competitive awards demonstrating AmerisourceBergen's capability to fulfill federal medical supply requirements. The company's federal contract portfolio encompasses a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The SPE2DX prime vendor contract functions as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply critical medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with the DLA planning future regional contract awards under the Pharmaceutical Prime Vendor Global Program Generation V initiative.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/10/25 |